PhRMA’s Seven-Figure 340B Ad Blitz vs. TrumpRx Lobbying Surge
PhRMA launched a costly ad campaign targeting 340B discounts while its lobbying efforts spiked amid TrumpRx partnerships, revealing Big Pharma’s quiet investment in influence.
Policy Influence
End of content
End of content